Health Care Digest: Genentech's blood cancer win, a boost for Gilead's HIV PrEP and a tiny IPO swings at antibiotics
November 26, 2018 at 10:04 AM EST
Why a South Bay company thinks it can disrupt a tough antibiotics market — and more in our weekly Health Care Digest.
